This inventor holds 25 USPTO granted patents and 12 published patent applications, plus 12 CIPO patents and 24 EPO patents, primarily in Cellulose Treatment. Top assignees: Ab Enzymes Oy, Roal Oy, Ab Enzymes Gmbh. Active years: 2008-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nurmijarvi, FI (2008 - 2016)
- Nurmijärvi, FI (2010 - 2019)
- Hyvinkää, FI (2020)
- Rajamäki, FI (2018 - 2024)
- Nurmijaervi, FI (2024)
Company Filing History:



Years Active: 2008-2025
Areas of Expertise:
Title: Terhi Puranen: Innovator in Protein Production
Introduction: Terhi Puranen, based in Nurmijärvi, Finland, is a distinguished inventor in the field of protein production. With an impressive portfolio of 23 patents, Puranen has made substantial contributions to biotechnology, particularly focusing on enhancing protease production.
Latest Patents: Among Puranen's latest innovations are groundbreaking methods for controlling protease production. These patents introduce novel host cells characterized by low protease activity, innovative protease regulators, and their applications in expression systems and protein production. The methods developed also detail processes for producing host cells aimed explicitly at improving protein production efficiency.
Career Highlights: Throughout his career, Terhi Puranen has worked with notable companies in the biotechnology sector, including Ab Enzymes and Roal Oy. His expertise in the field has played an essential role in advancing company projects and fostering innovation in protein engineering.
Collaborations: Terhi Puranen has collaborated with prominent colleagues such as Jari Vehmaanperä and Leena Valtakari. These collaborative efforts have significantly contributed to the successful development and implementation of his patented methods and innovations in protein production.
Conclusion: Terhi Puranen stands out as a leading figure in protein production innovation. With his extensive patent portfolio and ongoing collaborations, he continues to influence the future of biotechnological advancements, offering new methodologies that promise to enhance the efficiency of protein production processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile